Back to LTRN

BIOS Capital Management, LP → LTRN

BIOS Capital Management, LP LTRN Position History

Lantern Pharma Inc. • Healthcare

Quarters held
4
Latest value
$238.3M
Q3 2026
Peak value
$238.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$3.1M
Q1 2026$1.2M
Q2 2026$1M
Q3 2026$238.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$238.3M235.9K——
Q2 2026$1M249.4K——
Q1 2026$1.2M864.4K——
Q4 2025$3.1M1.01M——

Other funds holding LTRN

Other BIOS Capital Management, LP positions

IRD

OPUS GENETICS INC

$17.8B
CGTX

COGNITION THERAPEUTICS INC

$5.3B
CGTX

COGNITION THERAPEUTICS INC

$480.1M
IRD

OPUS GENETICS INC

$16.8M
IRD

OPUS GENETICS INC

$15.1M
CGTX

COGNITION THERAPEUTICS INC

$7.4M
IRD

OPUS GENETICS INC

$7.4M
CGTX

COGNITION THERAPEUTICS INC

$6.3M